PLEXUS
Live / Registered — Registered — international registration renewed (as of 11 Jul 2022)
What this means for you
Registered since 23 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79171662
- Registration number
- 5024473
- Mark type
- Stylized text
- Filed
- 22 Dec 2014
- Published for opposition
- 07 Jun 2016
- Registered
- 23 Aug 2016
- Attorney of record
- Megan E. Fink
Goods and services
- Class 010 — Medical apparatus: Surgical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease, namely, thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems and devices comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft devices; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, namely, surgical mesh comprised primarily of prosthetic materials; medical apparatus and instruments for use in endovascular procedures and for treating cardiovascular disease; grafts, namely, prosthetic vascular grafts, prosthetic endovascular grafts, stents, and vascular prostheses; prosthetic vascular woven grafts; surgical implants comprising prosthetic materials; stents, patches, namely, patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; prostheses, namely, artificial surgical prostheses; surgical implants comprising artificial material; suture materials; patches for repair and reconstruction of internal tissue, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, synthetic heart valve conduits, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; artificial vascular grafts; artificial endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, vascular prostheses for the treatment of aneurysmal or occlusive arterial disease medical devices for use in endovascular procedures for treating cardiovascular disease; stents; thoracic stents; artificial thoracic stent grafts; thoracic stent graft systems comprising synthetic stent grafts and stent delivery systems; delivery systems for stent graft systems comprising stent delivery systems; aneurysm repair systems comprised of catheter delivered artificial stent grafts and stent delivery systems; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac valves; artificial heart valves; heart valve conduits namely, catheters for implanting heart valves; cardiac patches and vascular patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods
Owner
- Vascutek Limited, Renfrewshire, GB
- Vascutek Limited, GB
- Vascutek Limited, GB
Prosecution history
- 20 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Aug 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 24 Oct 2024 — INTERNATIONAL REGISTRATION RENEWED
- 11 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 11 Jul 2022 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 06 Jun 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Dec 2021 — TEAS SECTION 71 & 15 RECEIVED
- 23 Aug 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 17 Feb 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Jan 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Jan 2017 — FINAL DISPOSITION PROCESSED